Brief: Heron Therapeutics' Preliminary Annual Net Product Sales 24% In 2022

Heron Therapeutics

09/01/2023 14:08

Jan 9 (Reuters) - Heron Therapeutics Inc  HRTX.O :
    * PRELIMINARY ANNUAL NET PRODUCT SALES ACROSS CO GREW 24% TO
$106.7 MILLION IN 2022, COMPARED TO ANNUAL NET PRODUCT SALES IN
2021
    * PRELIMINARY FOURTH-QUARTER 2022 NET PRODUCT SALES FOR
ZYNRELEF
INCREASED 40% TO ABOUT $3.8 MILLION
    * PRELIMINARY FY 2022 NET PRODUCT SALES FOR ONCOLOGY CARE
FRANCHISE OF ABOUT $96.6 MILLION, VERSUS OUTLOOK OF $93 MILLION
TO $95 MILLION
    * SEES FULL-YEAR 2023 NET PRODUCT SALES GUIDANCE FOR
ONCOLOGY CARE
FRANCHISE OF $99 MILLION TO $103 MILLION

Source text for Eikon:  ID:nPn5Hjzqga 
Further company coverage:  HRTX.O 
 ((Reuters.Briefs@thomsonreuters.com))